360 results on '"Lightner, Amy L."'
Search Results
2. Surgical Options for the Treatment of Perianal and Anovaginal Fistulas in the Setting of Ileoanal Pouch Crohn’s Disease: Experience of a Tertiary Center
3. Disease Burden, Treatment Patterns, and Economic Impact of Rectovaginal Fistulas in Patients with Crohn’s Disease: Findings from a Retrospective, Observational, Longitudinal Study Based on US Claims Databases
4. Patient engagement and satisfaction with early phase cell therapy clinical trials at a tertiary inflammatory bowel disease center
5. Treatment effect of ex vivo expanded allogeneic bone marrow–derived mesenchymal stem cells for the treatment of fistulizing Crohn’s disease are durable at 12 months
6. A phase IB/IIA study of ex vivo expanded allogeneic bone marrow–derived mesenchymal stem cells for the treatment of rectovaginal fistulizing Crohn’s disease
7. Perianal Fistulizing Crohn’s Disease: Utilizing the TOpClass Classification in Clinical Practice to Provide Targeted Individualized Care
8. Perianal Fistulizing Crohn’s Disease–Associated Anorectal and Fistula Cancers: Systematic Review and Expert Consensus
9. Bone Marrow Mesenchymal Stem Cell-Derived Extracellular Vesicle Infusion for the Treatment of Respiratory Failure From COVID-19: A Randomized, Placebo-Controlled Dosing Clinical Trial
10. Clinical practice guidelines for enhanced recovery after colon and rectal surgery from the American Society of Colon and Rectal Surgeons and the Society of American Gastrointestinal and Endoscopic Surgeons
11. Appropriateness of Medical and Surgical Treatments for Chronic Pouchitis Using RAND/UCLA Appropriateness Methodology
12. Outcomes of clostridioides difficile infection on inflammatory bowel disease patients undergoing colonic resection: A propensity score weighted NSQIP analysis
13. Entero-Gynecologic Fistula: A Rare Complication of Penetrating Crohn’s Disease
14. Test Characteristics of Cross-sectional Imaging and Concordance With Endoscopy in Postoperative Crohn’s Disease
15. CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease
16. New insights on the surgical management of ulcerative colitis in the 21st century
17. Cost-Effectiveness of Aspirin for Extended Venous Thromboembolism Prophylaxis After Major Surgery for Inflammatory Bowel Disease
18. Classifying perianal fistulising Crohn's disease: an expert consensus to guide decision-making in daily practice and clinical trials
19. Surgical Management of Crohn's Disease
20. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for Preventing Surgical Site Infection.
21. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Evaluation and Management of Chronic Constipation.
22. Perioperative management of biologic agents in Crohn's disease
23. Perioperative management of biologic agents in ulcerative colitis
24. Timing and outcome of right- vs left-sided colonic anastomotic leaks: Is there a difference?
25. Surgical intervention for mechanical large bowel obstruction at a tertiary hospital: Which patients receive a stoma and how often are they reversed?
26. Stem Cells and Stem Cell-Derived Factors for the Treatment of Inflammatory Bowel Disease with a Particular Focus on Perianal Fistulizing Disease: A Minireview on Future Perspectives.
27. Fistulizing Crohn's disease
28. Diverticulitis: An Update From the Age Old Paradigm
29. Challenges in Crohn's disease: Complex perianal Crohn's disease
30. Perioperative and Postoperative Management of Patients With Crohn’s Disease and Ulcerative Colitis
31. The Cumulative Incidence of Pouchitis in Pediatric Patients With Ulcerative Colitis
32. Precision regenerative medicine
33. Preoperative Considerations in Inflammatory Bowel Disease
34. Risk factors for 90-day readmission and return to the operating room following abdominal operations for Crohn’s disease
35. Body mass index: Implications on disease severity and postoperative complications in patients with Crohn’s disease undergoing abdominal surgery
36. Anti-TNF biologic therapy does not increase postoperative morbidity in pediatric Crohn's patients
37. Incision & drainage of perianal sepsis in the immunocompromised: A need for heightened postoperative awareness
38. Surgery During Admission for an Ulcerative Colitis Flare: Should Pouch Formation Be Considered?
39. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Colon Cancer
40. Pouch Function Over Time and With Advancing Age
41. Expert Commentary on Postoperative Evaluation and Management of Portomesenteric Venous Thrombosis in Patients With Inflammatory Bowel Disease
42. Mesenteric Excision and Exclusion for Ileocolic Crohn’s Disease: Feasibility and Safety of an Innovative, Combined Surgical Approach With Extended Mesenteric Excision and Kono-S Anastomosis
43. Factors Influencing Colon and Rectal Surgery Residency Program Selection
44. Do medications affect outcomes in pelvic pouch construction?
45. Bone marrow mesenchymal stem cell-derived extracellular vesicle infusion for amyotrophic lateral sclerosis.
46. Tofacitinib Is Associated With Increased Risk of Postoperative Venous Thromboembolism in Patients With Ulcerative Colitis.
47. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Hemorrhoids.
48. The Fate of Unifocal Versus Multifocal Low-Grade Dysplasia at the Time of Colonoscopy in Patients With IBD
49. Anal Squamous Cell Carcinoma in Ulcerative Colitis: Can Pouches Withstand Traditional Treatment Protocols?
50. Risk factors for readmission following ileal pouch–Anal anastomosis: an American College of Surgeons National Surgical Quality Improvement Program analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.